161 related articles for article (PubMed ID: 1964954)
1. Regulation of squalene epoxidase in HepG2 cells.
Hidaka Y; Satoh T; Kamei T
J Lipid Res; 1990 Nov; 31(11):2087-94. PubMed ID: 1964954
[TBL] [Abstract][Full Text] [Related]
2. Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in Hep G2 cells.
Hidaka Y; Hotta H; Nagata Y; Iwasawa Y; Horie M; Kamei T
J Biol Chem; 1991 Jul; 266(20):13171-7. PubMed ID: 1649182
[TBL] [Abstract][Full Text] [Related]
3. Regulation of squalene epoxidase activity in rat liver.
Satoh T; Hidaka Y; Kamei T
J Lipid Res; 1990 Nov; 31(11):2095-101. PubMed ID: 2086706
[TBL] [Abstract][Full Text] [Related]
4. Effect of FR194738, a potent inhibitor of squalene epoxidase, on cholesterol metabolism in HepG2 cells.
Sawada M; Matsuo M; Hagihara H; Tenda N; Nagayoshi A; Okumura H; Washizuka K; Seki J; Goto T
Eur J Pharmacol; 2001 Nov; 431(1):11-6. PubMed ID: 11716837
[TBL] [Abstract][Full Text] [Related]
5. Regulation of squalene synthetase in human hepatoma cell line Hep G2 by sterols, and not by mevalonate-derived non-sterols.
Cohen LH; van Miert E; Griffioen M
Biochim Biophys Acta; 1989 Mar; 1002(1):69-73. PubMed ID: 2538145
[TBL] [Abstract][Full Text] [Related]
6. An inhibitor of squalene epoxidase, NB-598, suppresses the secretion of cholesterol and triacylglycerol and simultaneously reduces apolipoprotein B in HepG2 cells.
Horie M; Hayashi M; Satoh T; Hotta H; Nagata Y; Ishida F; Kamei T
Biochim Biophys Acta; 1993 May; 1168(1):45-51. PubMed ID: 8504141
[TBL] [Abstract][Full Text] [Related]
7. Regulation of squalene epoxidase activity and comparison of catalytic properties of rat liver and Chinese hamster ovary cell-derived enzymes.
Eilenberg H; Shechter I
J Lipid Res; 1987 Dec; 28(12):1398-404. PubMed ID: 3430067
[TBL] [Abstract][Full Text] [Related]
8. Regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA contents in human hepatoma cell line Hep G2 by distinct classes of mevalonate-derived metabolites.
Cohen LH; Griffioen M
Biochem J; 1988 Oct; 255(1):61-7. PubMed ID: 2848511
[TBL] [Abstract][Full Text] [Related]
9. Inactivation and activation of various membranal enzymes of the cholesterol biosynthetic pathway by digitonin.
Eilenberg H; Klinger E; Przedecki F; Shechter I
J Lipid Res; 1989 Aug; 30(8):1127-35. PubMed ID: 2504860
[TBL] [Abstract][Full Text] [Related]
10. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
[TBL] [Abstract][Full Text] [Related]
11. Supernatant protein factor stimulates HMG-CoA reductase in cell culture and in vitro.
Mokashi V; Singh DK; Porter TD
Arch Biochem Biophys; 2005 Jan; 433(2):474-80. PubMed ID: 15581604
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic properties of squalene epoxidase from Saccharomyces cerevisiae.
Satoh T; Horie M; Watanabe H; Tsuchiya Y; Kamei T
Biol Pharm Bull; 1993 Apr; 16(4):349-52. PubMed ID: 8358382
[TBL] [Abstract][Full Text] [Related]
13. [Activities of 3-hydroxyl-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and the rate of mevalonic acid, squalene, sterol and fatty acid biosynthesis from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: effects of Triton WR 1339, starvation and cholesterol diet].
Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
Biokhimiia; 1981 Feb; 46(2):296-305. PubMed ID: 6113854
[TBL] [Abstract][Full Text] [Related]
14. Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro.
Correll CC; Edwards PA
J Biol Chem; 1994 Jan; 269(1):633-8. PubMed ID: 8276863
[TBL] [Abstract][Full Text] [Related]
15. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity.
Boogaard A; Griffioen M; Cohen LH
Biochem J; 1987 Jan; 241(2):345-51. PubMed ID: 3036060
[TBL] [Abstract][Full Text] [Related]
16. Roles of phospholipid and detergent in soluble protein activation of squalene epoxidase.
Lin LF
Biochemistry; 1980 Oct; 19(22):5135-40. PubMed ID: 7459326
[TBL] [Abstract][Full Text] [Related]
17. Squalene epoxidase as hypocholesterolemic drug target revisited.
Chugh A; Ray A; Gupta JB
Prog Lipid Res; 2003 Jan; 42(1):37-50. PubMed ID: 12467639
[TBL] [Abstract][Full Text] [Related]
18. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase: search for the enzyme's repressor derived from mevalonate.
Popják G; Meenan A
Proc R Soc Lond B Biol Sci; 1987 Sep; 231(1265):391-414. PubMed ID: 2892200
[TBL] [Abstract][Full Text] [Related]
19. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
Qin W; Infante J; Wang SR; Infante R
Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
[TBL] [Abstract][Full Text] [Related]
20. Effects of compactin, mevalonate and low-density lipoprotein on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2.
Cohen LH; Griffioen M; Havekes L; Schouten D; van Hinsbergh V; Kempen HJ
Biochem J; 1984 Aug; 222(1):35-9. PubMed ID: 6089762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
